Ladenburg Thalmann Financial Services’s Corvus Pharmaceuticals CRVS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-15,350	Closed	-$220K	–	4854
2016 Q4	$220K	Buy	15,350 +5,900	+62%	+$84.6K	﹤0.01%	1754
2016 Q3	$155K	Buy	+9,450	New	+$155K	﹤0.01%	1928